An observational, prospective study to monitor effectiveness and safety of dual therapy of lamivudine plus lopinavir/ritonavir and darunavir/ritonavir in naïve and treatment-experienced HIV-positive patients in a real-world setting.

Trial Profile

An observational, prospective study to monitor effectiveness and safety of dual therapy of lamivudine plus lopinavir/ritonavir and darunavir/ritonavir in naïve and treatment-experienced HIV-positive patients in a real-world setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Darunavir/ritonavir; Lamivudine
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top